The Public Health Agency of Canada’s integrated bio-behavioural surveillance system—Tracks surveys—assesses the burden of HIV, hepatitis C and associated risks in key populations in Canada
Summary of the provincial and territorial coverage of antiretroviral therapy in Canada. Data was collected from secondary data sources between September and December 2022
This document updates national standards for management of adults living with both HIV and HCV in the Canadian context with evolving evidence for and accessibility of effective and tolerable DAA therapies.
This document updates national standards for management of adults living with both HIV and HCV in the Canadian context with evolving evidence for and accessibility of effective and tolerable DAA therapies.